Rossari Biotech Downgraded to 'Hold' by MarketsMOJO, Despite Strong Growth Potential
Rossari Biotech, a smallcap company in the chemicals industry, has been downgraded to a 'Hold' by MarketsMojo due to its recent underperformance in the market. However, the company has a strong financial position with a low Debt to Equity ratio and has shown positive results in the past quarter. Its stock is currently in a Mildly Bullish range and trading at a discount, making it an attractive option for investors. However, its underperformance in the past year and fair valuation may warrant a 'Hold' rating for now.
Rossari Biotech, a smallcap company in the chemicals industry, has recently been downgraded to a 'Hold' by MarketsMOJO on October 3, 2024. This decision was based on the company's current financial standing and market performance.One of the reasons for the downgrade is the company's low Debt to Equity ratio, which is at 0 times on average. This indicates a healthy financial position and lower risk for investors.
However, Rossari Biotech has shown a strong long-term growth potential with an annual growth rate of 34.60% in Net Sales. In addition, the company has also reported positive results in the quarter ending June 2024, with the highest PBT LESS OI (Q) at Rs 46.04 crore, highest NET SALES (Q) at Rs 489.65 crore, and highest PBDIT (Q) at Rs 64.88 crore.
From a technical standpoint, the stock is currently in a Mildly Bullish range and the KST (Know Sure Thing) indicator has been Bullish since October 3, 2024. This could indicate a potential upward trend in the stock's performance.
With a ROE (Return on Equity) of 12.5, the stock is currently trading at a Fair valuation with a Price to Book Value of 4.7. It is also trading at a discount compared to its average historical valuations, making it an attractive option for investors.
However, in the past year, Rossari Biotech has underperformed the market with a return of only 8.86%, while the market (BSE 500) has generated a return of 36.98%. This could be a cause for concern for investors.
It is worth noting that the company has a high institutional holding of 20.7%, indicating that these investors have better resources and capabilities to analyze the fundamentals of the company compared to retail investors.
Overall, while Rossari Biotech has shown potential for long-term growth and has a healthy financial position, its recent underperformance in the market and fair valuation may warrant a 'Hold' rating for now. Investors should keep an eye on the company's future performance and market trends before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
